Affiliations
AffiliationsItem in Clipboard
Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in ItalyCarlo Senore et al. Gut. 2020 Mar.
. 2020 Mar;69(3):523-530. doi: 10.1136/gutjnl-2018-318198. Epub 2019 Aug 27. Authors Carlo Senore 1 , Marco Zappa 2 , Cinzia Campari 3 , Sergio Crotta 4 , Paola Armaroli 5 , Arrigo Arrigoni 6 , Paola Cassoni 7 , Rossana Colla 3 , Mario Fracchia 8 , Fabrizio Gili 9 , Grazia Grazzini 10 , Roberto Lolli 11 , Patrizia Menozzi 3 , Lorenzo Orione 12 , Salvatore Polizzi 13 , Stefano Rapi 14 , Emilia Riggi 5 , Tiziana Rubeca 10 , Romano Sassatelli 3 , Carmen Visioli 2 , Nereo Segnan 5 AffiliationsItem in Clipboard
AbstractObjective: To estimate the predictive role of faecal haemoglobin (f-Hb) concentration among subjects with faecal immunochemical test (FIT) results below the positivity cut-off for the subsequent risk of advanced neoplasia (AN: colorectal cancer-CRC-or advanced adenoma).
Design: Prospective cohort of subjects aged 50-69 years, undergoing their first FIT between 1 January 2004 and 31 December 2010 in four population-based programmes in Italy.
Methods: All programmes adopted the same analytical procedure (OC Sensor, Eiken Japan), performed every 2 years, on a single sample, with the same positivity cut-off (20 µg Hb/g faeces). We assessed the AN risk at subsequent exams, the cumulative AN detection rate (DR) over the 4-year period following the second FIT and the interval CRC (IC) risk following two negative FITs by cumulative amount of f-Hb concentration over two consecutive negative FITs, using multivariable logistic regression models and the Kaplan-Meier method.
Results: The cumulative probability of a positive FIT result over the subsequent two rounds ranged between 7.8% (95% CI 7.5 to 8.2) for subjects with undetectable f-Hb at the initial two tests (50% of the screenees) and 48.4% (95% CI 44.0 to 53.0) among those (0.7% of the screenees) with a cumulative f-Hb concentration ≥20 µg/g faeces. The corresponding figures for cumulative DR were: 1.4% (95% CI 1.3 to 1.6) and 25.5% (95% CI 21.4 to 30.2) for AN; 0.17% (95% CI 0.12 to 0.23) and 4.5% (95% CI 2.8 to 7.1) for CRC. IC risk was also associated with cumulative f-Hb levels.
Conclusion: The association of cumulative f-Hb concentration with subsequent AN and IC risk may allow to design tailored strategies to optimise the utilisation of endoscopy resources: subjects with cumulative f-Hb concentration ≥20 µg/g faeces over two negative tests could be referred immediately for total colonoscopy (TC), while screening interval might be extended for those with undetectable f-Hb.
Keywords: CRC screening; FIT; advanced adenoma.
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statementCompeting interests: None declared.
Similar articlesDigby J, Cleary S, Gray L, Datt P, Goudie DR, Steele RJC, Strachan JA, Humphries A, Fraser CG, Mowat C. Digby J, et al. United European Gastroenterol J. 2020 Jun;8(5):559-566. doi: 10.1177/2050640620913674. Epub 2020 Mar 16. United European Gastroenterol J. 2020. PMID: 32213041 Free PMC article.
de Klerk CM, Wieten E, Lansdorp-Vogelaar I, Bossuyt PM, Spaander MC, Dekker E. de Klerk CM, et al. Lancet Gastroenterol Hepatol. 2019 Feb;4(2):111-118. doi: 10.1016/S2468-1253(18)30319-4. Epub 2018 Nov 27. Lancet Gastroenterol Hepatol. 2019. PMID: 30497962
Grobbee EJ, Wisse PHA, Schreuders EH, van Roon A, van Dam L, Zauber AG, Lansdorp-Vogelaar I, Bramer W, Berhane S, Deeks JJ, Steyerberg EW, van Leerdam ME, Spaander MC, Kuipers EJ. Grobbee EJ, et al. Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD009276. doi: 10.1002/14651858.CD009276.pub2. Cochrane Database Syst Rev. 2022. PMID: 35665911 Free PMC article. Review.
Zorzi M, Hassan C, Capodaglio G, Fedato C, Montaguti A, Turrin A, Rosano A, Monetti D, Stocco C, Baracco S, Russo F, Repici A, Rugge M. Zorzi M, et al. Gut. 2018 Dec;67(12):2124-2130. doi: 10.1136/gutjnl-2017-314753. Epub 2017 Nov 3. Gut. 2018. PMID: 29101260
Westwood M, Corro Ramos I, Lang S, Luyendijk M, Zaim R, Stirk L, Al M, Armstrong N, Kleijnen J. Westwood M, et al. Health Technol Assess. 2017 May;21(33):1-234. doi: 10.3310/hta21330. Health Technol Assess. 2017. PMID: 28643629 Free PMC article. Review.
van Stigt BJ, Lansdorp-Vogelaar I, Spaander MCW, van Vuuren AJ, Dekker E, van Kemenade FJ, Nagtegaal ID, van Leerdam ME, Toes-Zoutendijk E. van Stigt BJ, et al. Int J Cancer. 2025 May 1;156(9):1783-1790. doi: 10.1002/ijc.35294. Epub 2024 Dec 19. Int J Cancer. 2025. PMID: 39697047 Free PMC article.
Ribe SG, Botteri E, Løberg M, Randel KR, Kalager M, Nilsen JA, Gulichsen EH, Holme Ø. Ribe SG, et al. Int J Cancer. 2023 Apr 1;152(7):1414-1424. doi: 10.1002/ijc.34351. Epub 2022 Nov 21. Int J Cancer. 2023. PMID: 36346118 Free PMC article.
Breekveldt ECH, Toes-Zoutendijk E, de Jonge L, Spaander MCW, Dekker E, van Kemenade FJ, van Vuuren AJ, Ramakers CRB, Nagtegaal ID, van Leerdam ME, Lansdorp-Vogelaar I. Breekveldt ECH, et al. BMC Gastroenterol. 2023 Feb 22;23(1):45. doi: 10.1186/s12876-023-02670-1. BMC Gastroenterol. 2023. PMID: 36814185 Free PMC article.
Mowat C, Digby J, Cleary S, Gray L, Datt P, Goudie DR, Steele RJ, Strachan JA, Humphries A, Fraser CG. Mowat C, et al. Ann Clin Biochem. 2022 Jul;59(4):272-276. doi: 10.1177/00045632221080897. Epub 2022 Mar 2. Ann Clin Biochem. 2022. PMID: 35235491 Free PMC article.
Breekveldt ECH, Toes-Zoutendijk E, van de Schootbrugge-Vandermeer HJ, de Jonge L, Kooyker AI, Spaander MCW, van Vuuren AJ, van Kemenade FJ, Ramakers C, Dekker E, Nagtegaal ID, van Leerdam ME, Lansdorp-Vogelaar I. Breekveldt ECH, et al. Int J Cancer. 2023 Apr 15;152(8):1536-1546. doi: 10.1002/ijc.34373. Epub 2022 Dec 1. Int J Cancer. 2023. PMID: 36444504 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3